
Thursday, January 23, 2025 8:47:03 AM
The stock price has decreased by -85.16% in the last 52 weeks.
BNGO has 101.99 million shares outstanding. The number of shares has increased by 94.65% in one year. DILUTION!!!
In the last 12 months, BNGO had revenue of $33.33 million and -$135.78 million in losses. Loss per share was -$2.21.
The last stock split was on August 7, 2023. It was a reverse split with a ratio of 10 for 1, and in 2025, the reverse split will be 60 for 1.
BNGO has a “Piotroski” F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
The latest short interest is 17.65 million, so 17.31% of the outstanding shares have been sold short.
BNGO has a market cap or net worth of $18.92 million. The enterprise value is $29.42 million.
BNGO has an “ALTMAN” Z-Score of -13.29.
(The Altman Z-Score is a formula used to predict the likelihood of a business going bankrupt within the next two years. A score below 1.8 generally suggests a high probability of bankruptcy, and a score as low as -13.29 is extremely alarming.)
BNGO has a “PIOTROSKI” F Score of 2.
(The Piotroski F-Score is a tool used to evaluate a company's financial strength based on nine criteria, with a score ranging from 0 to 92. A score of 2 means that the company only meets two of these criteria, suggesting significant financial distress and a higher risk of bankruptcy.)
Revvity has a market cap or net worth of $14.94 billion as of January 23, 2025. Its market cap has increased by 12.41% in one year.
Volume: | 108,161 |
Day Range: | 3.46 - 3.76 |
Bid: | 3.46 |
Ask: | 4.17 |
Last Trade Time: | 7:46:12 PM EDT |
Total Trades: | 1,544 |
Recent BNGO News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/21/2025 09:20:40 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 02/21/2025 09:16:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/19/2025 11:57:21 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/19/2025 11:57:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/19/2025 11:56:56 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/19/2025 11:56:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/19/2025 11:56:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/10/2025 10:16:12 PM
- Bionano Announces Effective Date of Reverse Stock Split • GlobeNewswire Inc. • 01/22/2025 09:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/16/2025 09:36:40 PM
- Bionano Announces Use of OGM in Preimplantation Genetic Testing as Part of Successful Live Birth to a Couple Experiencing Recurrent Pregnancy Loss • GlobeNewswire Inc. • 01/14/2025 01:00:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 01/14/2025 11:15:16 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/13/2025 09:11:06 PM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 01/13/2025 02:52:41 PM
- Bionano Reports Preliminary Fourth Quarter and Full-Year 2024 Results • GlobeNewswire Inc. • 01/13/2025 01:00:00 PM
- Form S-3/A - Registration statement under Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 01/08/2025 10:29:30 PM
- Bionano Announces Publication Showing that OGM Identifies Variant that Indicates Use of Proven Therapy in Acute Promyelocytic Leukemia • GlobeNewswire Inc. • 01/07/2025 01:00:00 PM
- Bionano Announces Closing of $10 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules • GlobeNewswire Inc. • 01/06/2025 09:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/06/2025 12:10:36 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 01/06/2025 12:00:46 PM
- Bionano Announces $10 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules • GlobeNewswire Inc. • 01/03/2025 07:34:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/03/2025 01:30:17 PM
- Bionano Announces Amendment to Senior Secured Convertible Debentures in Debt Restructuring that Improves Cash Runway • GlobeNewswire Inc. • 12/31/2024 08:26:02 PM
- Bionano Announces Publication from Johns Hopkins School of Medicine Showing that OGM Outperformed Multiple Cytogenetic Assays in a Study of Bone and Soft Tissue Tumor Analysis • GlobeNewswire Inc. • 12/23/2024 01:30:00 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 12/19/2024 01:06:25 PM
FEATURED 1606 Corp. Signs LOI to Be Acquired by Private Group Seeking to Enter the Public Markets and Utilize AI Technologies for Potential Uplisting • Mar 11, 2025 8:30 AM
$PYPD - PolyPid Hits Major Milestone: Completes Trial Enrollment, Poised for Potential Breakthrough in $10 Billion Surgical Infection Market • NRXS • Mar 11, 2025 10:30 AM
UC Asset Acquired $3M Cannabis Property via Non-Cash Deal • UCASU • Mar 11, 2025 9:53 AM
Northstrive Biosciences Inc. Schedules Pre-IND Meeting with FDA for EL-22, an Obesity Therapy Targeting Fat Loss and Muscle Preservation in Combination with GLP-1 • ELAB • Mar 10, 2025 9:05 AM
North Bay Resources Announces Assays up to 5.69% Copper, 1 Opt. Silver, and 0.22% Vanadium at Copper Island Project, British Columbia • NBRI • Mar 10, 2025 9:00 AM
Avant Technologies and JV Partner, Ainnova, Strategically Align with Apollo Hospitals to Advance AI in Healthcare • AVAI • Mar 10, 2025 8:00 AM